Opko Health (OPK) Posts Q1 Loss of 11c/Share
Tweet
Share
E-mailGet Alerts OPK Hot Sheet
Price: $1.63 --0%
Revenue Growth %: -11.2%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -11.2%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Opko Health (NYSE: OPK) reported Q1 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $22.3 million versus the consensus estimate of $22.77 million.
For earnings history and earnings-related data on Opko Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens on INBRX-106 Ph2 Results
- Jana Partners urges Cooper Companies to replace CEO and explore asset sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
